Innospec Valuation
| IOSP Stock | USD 114.47 1.57 1.39% |
At this time, the firm appears to be undervalued. Innospec retains a regular Real Value of $123.52 per share. The prevalent price of the firm is $114.47. Our model calculates the value of Innospec from evaluating the firm fundamentals such as Current Valuation of 2.56 B, return on equity of 0.12, and Return On Asset of 0.0724 as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Innospec's valuation include:
Price Book 2.2679 | Enterprise Value | Enterprise Value Ebitda 11.3454 | Price Sales 1.5032 | Forward PE 18.9036 |
Undervalued
Today
Please note that Innospec's price fluctuation is very steady at this time. Calculation of the real value of Innospec is based on 3 months time horizon. Increasing Innospec's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Innospec's intrinsic value may or may not be the same as its current market price of 114.47, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 114.47 | Real 123.52 | Target 132.5 | Hype 114.41 |
The intrinsic value of Innospec's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Innospec's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Innospec helps investors to forecast how Innospec stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Innospec more accurately as focusing exclusively on Innospec's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Innospec's intrinsic value based on its ongoing forecasts of Innospec's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Innospec's closest peers.
Innospec Cash |
|
Innospec Valuation Trend
Innospec's real value is important for investors to make better decisions and a more accurate overall view of Innospec's financial worth over time. Using both Innospec's enterprise value as well as its market capitalization is the best way to gauge the value of the company and is usually enough for investors to make market timing conclusions.
Innospec Revenue by Product
Innospec Total Value Analysis
Innospec is currently projected to have valuation of 2.56 B with market capitalization of 2.82 B, debt of 45.2 M, and cash on hands of 71.4 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Innospec fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
2.56 B | 2.82 B | 45.2 M | 71.4 M |
Innospec Investor Information
About 98.0% of the company shares are owned by institutional investors. The book value of Innospec was currently reported as 49.85. The company recorded earning per share (EPS) of 5.73. Innospec last dividend was issued on the 18th of November 2024. The entity had 2:1 split on the 23rd of July 2007. Based on the measurements of operating efficiency obtained from Innospec's historical financial statements, Innospec is not in a good financial situation at this time. It has a very high probability of going through financial hardship in February.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Profit Margin | 0.12 | 0.0954 |
|
| |||||
| Total Cash From Operating Activities | 250.3 M | 238.4 M |
|
| |||||
| Operating Income | 97.1 M | 185.8 M |
|
|
Innospec Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Innospec has an asset utilization ratio of 114.14 percent. This connotes that the Company is making $1.14 for each dollar of assets. An increasing asset utilization means that Innospec is more efficient with each dollar of assets it utilizes for everyday operations.Innospec Ownership Allocation
Innospec has a total of 24.94 Million outstanding shares. The majority of Innospec outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Innospec to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Innospec. Please pay attention to any change in the institutional holdings of Innospec as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Innospec Profitability Analysis
The company reported the previous year's revenue of 1.95 B. Net Income was 139.1 M with profit before overhead, payroll, taxes, and interest of 567.4 M.Innospec Past Distributions to stockholders
About Innospec Valuation
The stock valuation mechanism determines Innospec's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Innospec based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Innospec. We calculate exposure to Innospec's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Innospec's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 679.8 M | 713.8 M | |
| Pretax Profit Margin | 0.10 | 0.10 | |
| Operating Profit Margin | 0.10 | 0.12 | |
| Net Profit Margin | 0.06 | 0.04 | |
| Gross Profit Margin | 0.35 | 0.39 |
Innospec Quarterly Retained Earnings |
|
A single share of Innospec represents a small ownership stake in the entity. As a stockholder of Innospec, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
Innospec Dividends Analysis For Valuation
Please note that Innospec has scaled down on payment of dividends at this time. At this time, Innospec's Retained Earnings are relatively stable compared to the past year. As of 01/18/2025, Earnings Yield is likely to grow to 0.08, while Retained Earnings Total Equity is likely to drop slightly above 628.1 M.
There are various types of dividends Innospec can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of Innospec shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Innospec directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When Innospec pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Innospec by the value of the dividends paid out.
Innospec Growth Indicators
Investing in growth stocks can be very risky. If the company such as Innospec does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 25 M | |
| Quarterly Earnings Growth Y O Y | -0.153 | |
| Forward Price Earnings | 18.9036 |
Innospec Current Valuation Indicators
Innospec's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Innospec's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Innospec, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Innospec's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Innospec's worth.Additional Tools for Innospec Stock Analysis
When running Innospec's price analysis, check to measure Innospec's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innospec is operating at the current time. Most of Innospec's value examination focuses on studying past and present price action to predict the probability of Innospec's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innospec's price. Additionally, you may evaluate how the addition of Innospec to your portfolios can decrease your overall portfolio volatility.